Search Results
Found 1 results
510(k) Data Aggregation
(180 days)
COLLAGEN TENDON SHEET-D
Collagen Tendon Sheet-D is indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.
Collagen Tendon Sheet-D is a resorbable type I collagen matrix that provides a layer of collagen over injured tendons. Collagen Tendon Sheet-D is designed to provide a layer between the tendon and the surrounding tissue. When hydrated, Collagen Tendon Sheet-D is an easy-to-use, soft, pliable, nonfriable, porous collagen sheet. Collagen Tendon Sheet-D is provided sterile, non-pyrogenic, for single use only, in a variety of sizes, in double peel packages.
This 510(k) summary (K122048) describes the Collagen Tendon Sheet-D, a resorbable type I collagen matrix. The submission primarily focuses on demonstrating substantial equivalence to a predicate device (Collagen Tendon Sheet, K112423) through a comparison of technical characteristics and non-clinical studies. There is no information provided about a clinical study involving human participants, AI, or specific performance metrics like sensitivity, specificity, or accuracy for a device that relies on such evaluation.
Therefore, the following information is not available in the provided document:
- A table of acceptance criteria and reported device performance related to clinical outcomes.
- Sample size used for a test set (as no clinical test set for performance evaluation is described).
- Data provenance for a clinical test set.
- Number of experts used to establish ground truth.
- Qualifications of experts.
- Adjudication method for a test set.
- Multi-reader multi-case (MRMC) comparative effectiveness study.
- Effect size of human readers with AI vs. without AI.
- Standalone (algorithm only) performance.
- Type of ground truth used (expert consensus, pathology, outcomes data).
- Sample size for the training set.
- How the ground truth for the training set was established.
Based on the provided document, the device met the acceptance criteria by demonstrating substantial equivalence to a legally marketed predicate device through non-clinical studies.
Here's the relevant information that is available:
1. A table of acceptance criteria and the reported device performance:
Acceptance Criteria (Demonstration of Substantial Equivalence) | Reported Device Performance |
---|---|
Safety/Biocompatibility: | |
Cytotoxicity (agarose overlay, liquid and extract methods) | Passed |
Pyrogenicity | Passed |
Systemic toxicity | Passed |
Hemolysis | Passed |
Genotoxicity (bacterial and mammalian mutation, chromosomal aberration) | Passed |
Intracutaneous reactivity | Passed |
Muscle implantation tissue response tests | Passed |
Compliance with FDA Blue Book Memorandum G95-1 and ISO 10993-1 | Device passed all applicable testing. |
Material Characterization: | |
Chemical composition and purity (SDS-PAGE analysis, collagen typing, residual testing, viral inactivation) | Characterized; same as predicate device. |
Mechanical Characterization: | |
Density | Characterized; intended to demonstrate substantial equivalence with predicate. |
Strength | Characterized; intended to demonstrate substantial equivalence with predicate. |
Stiffness | Characterized; intended to demonstrate substantial equivalence with predicate. |
Tear resistance | Characterized; intended to demonstrate substantial equivalence with predicate. |
Compliance with FDA's Guidance for the Preparation of a Premarket Notification for a Surgical Mesh | Testing conducted in accordance with this guidance. |
2. Sample size used for the test set and the data provenance:
- Not applicable / Not provided. The submission focuses on non-clinical studies (in vitro and in vivo animal studies for biocompatibility, chemical, and mechanical characterization). There is no mention of a clinical test set involving human data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable / Not provided. Ground truth determination by experts is not described as part of this non-clinical testing.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not applicable / Not provided. No clinical test set or adjudication process is mentioned.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No such study was done or reported. This device is a medical implant (collagen matrix), not an AI diagnostic or assistive device, so MRMC studies involving AI assistance are not relevant to this submission.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
- No such study was done or reported. This device is a physical implant, not an algorithm.
7. The type of ground truth used:
- For biocompatibility: Standardized assay results (e.g., cell viability, toxicity assessments, tissue response).
- For material and mechanical characterization: Laboratory measurements and analytical techniques.
- Not applicable in the context of expert-derived clinical ground truth.
8. The sample size for the training set:
- Not applicable / Not provided. No training set, as this is not an AI/algorithmic device.
9. How the ground truth for the training set was established:
- Not applicable / Not provided. No training set for ground truth establishment.
Ask a specific question about this device
Page 1 of 1